Open AccessReal-World Experience with Lifitegrast Ophthalmic Solution (Xiidra®) in the US and Canada: Retrospective Study of Patient Characteristics, Treatment Patterns, and Clinical Effectiveness in 600 Patients with Dry Eye Disease
Author(s) -
John Hovanesian,
Kelly K. Nichols,
Mitchell Jackson,
James A Katz,
Arthur W.K. Chan,
Mrudula B. Glassberg,
Brigitte Sloesen,
Caroline Korves,
Catherine Nguyen,
Annie Syntosi
Publication year - 2021
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s296510
Subject(s) - medicine , ophthalmology , demographics , retrospective cohort study , blurred vision , depression (economics) , artificial tears , pediatrics , surgery , demography , macroeconomics , sociology , economics
This study evaluated real-world treatment of dry eye disease (DED) with lifitegrast.